CHM 0.00% 1.4¢ chimeric therapeutics limited

Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive, page-14

  1. 79 Posts.
    lightbulb Created with Sketch. 32
    not sure what the issue is - non dilutive financing based on govt guaranteed tax credits. This is common practice. Also extends the cash run way for the company….
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.